TITLE:
Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.

CONDITION:
Colorectal Neoplasms

INTERVENTION:
ZD6126

SUMMARY:

      The purpose of this study is to assess the Safety, Tolerability and Efficacy of ZD6126 in
      Combination with Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects with Metastatic
      Colorectal Cancer.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Metastatic colorectal carcinoma

          -  Suitable for first-line treatment of metastatic disease

        Exclusion Criteria:

          -  Peripheral neuropathy greater than Grade 1

          -  Adjuvant therapy within 6 months prior to study treatment

          -  Prior oxaliplatin

          -  Prior pelvic or whole abdomen radiation

          -  Any history of coronary angioplasty or history of myocardial infarction
      
